BALTIMORE--(BUSINESS WIRE)--Celsis In Vitro, Inc. (Celsis IVT) announced today that the United States Court of Appeals for the Federal Circuit in Washington, D.C. upheld a preliminary injunction against Life Technologies Corporation’s infringement of U.S. Patent No. 7,604,929 (the LiverPool™ patent). Life Technologies (Nasdaq:LIFE) is the parent corporation of the named co-defendants, Invitrogen Corporation and CellzDirect LLC (collectively, LTC). The LiverPool patent relates to methods for producing multi-cryopreserved hepatocytes.
